Literature DB >> 21258628

Controlling Platinum, Ruthenium and Osmium Reactivity for Anticancer Drug Design.

Pieter C A Bruijnincx1, Peter J Sadler.   

Abstract

Entities:  

Year:  2009        PMID： 21258628      PMCID： PMC3024542          DOI： 10.1016/S0898-8838(09)00201-3

Source DB:  PubMed          Journal:  Adv Inorg Chem        ISSN： 0898-8838            Impact factor:   3.282


× No keyword cloud information.
  77 in total

1.  Formation of platinated GG cross-links on DNA by photoactivation of a platinum(IV) azide complex.

Authors:  Jana Kaspárková; Fiona S Mackay; Viktor Brabec; Peter J Sadler
Journal:  J Biol Inorg Chem       Date:  2003-07-09       Impact factor: 3.358

Review 2.  Bioinorganic photochemistry: frontiers and mechanisms.

Authors:  Konrad Szaciłowski; Wojciech Macyk; Agnieszka Drzewiecka-Matuszek; Małgorzata Brindell; Grazyna Stochel
Journal:  Chem Rev       Date:  2005-06       Impact factor: 60.622

Review 3.  Developing new metal-based therapeutics: challenges and opportunities.

Authors:  Trevor W Hambley
Journal:  Dalton Trans       Date:  2007-10-04       Impact factor: 4.390

4.  Anti-tumour activity in non-small cell lung cancer models and toxicity profiles for novel ruthenium(II) based organo-metallic compounds.

Authors:  S M Guichard; R Else; E Reid; B Zeitlin; R Aird; M Muir; M Dodds; H Fiebig; P J Sadler; D I Jodrell
Journal:  Biochem Pharmacol       Date:  2005-12-19       Impact factor: 5.858

5.  Oxidation induced by the antioxidant glutathione (GSH).

Authors:  Holm Petzold; Peter J Sadler
Journal:  Chem Commun (Camb)       Date:  2008-06-05       Impact factor: 6.222

6.  Organometallic ruthenium(II) diamine anticancer complexes: arene-nucleobase stacking and stereospecific hydrogen-bonding in guanine adducts.

Authors:  Haimei Chen; John A Parkinson; Simon Parsons; Robert A Coxall; Robert O Gould; Peter J Sadler
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

7.  Ruthenation of duplex and single-stranded d(CGGCCG) by organometallic anticancer complexes.

Authors:  Hong-Ke Liu; Fuyi Wang; John A Parkinson; Juraj Bella; Peter J Sadler
Journal:  Chemistry       Date:  2006-08-07       Impact factor: 5.236

8.  Conformation of DNA modified by monofunctional Ru(II) arene complexes: recognition by DNA binding proteins and repair. Relationship to cytotoxicity.

Authors:  Olga Novakova; Jana Kasparkova; Vendula Bursova; Ctirad Hofr; Marie Vojtiskova; Haimei Chen; Peter J Sadler; Viktor Brabec
Journal:  Chem Biol       Date:  2005-01

9.  DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media.

Authors:  Hana Kostrhunova; Jakub Florian; Olga Novakova; Anna F A Peacock; Peter J Sadler; Viktor Brabec
Journal:  J Med Chem       Date:  2008-06-26       Impact factor: 7.446

10.  Half-sandwich arene ruthenium(II)-enzyme complex.

Authors:  Iain W McNae; Katy Fishburne; Abraha Habtemariam; Tina M Hunter; Michael Melchart; Fuyi Wang; Malcolm D Walkinshaw; Peter J Sadler
Journal:  Chem Commun (Camb)       Date:  2004-07-27       Impact factor: 6.222
View more
  28 in total

1.  Unusual Role of Excited State Mixing in the Enhancement of Photoinduced Ligand Exchange in Ru(II) Complexes.

Authors:  Lauren M Loftus; Ao Li; Kathlyn L Fillman; Philip D Martin; Jeremy J Kodanko; Claudia Turro
Journal:  J Am Chem Soc       Date:  2017-12-11       Impact factor: 15.419

2.  Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells.

Authors:  Daniela Buac; Sara Schmitt; George Ventro; Fathima Rani Kona; Q Ping Dou
Journal:  Mini Rev Med Chem       Date:  2012-10       Impact factor: 3.862

3.  Electronic Relaxation Pathways in Heavy-Atom-Free Photosensitizers Absorbing Near-Infrared Radiation and Exhibiting High Yields of Singlet Oxygen Generation.

Authors:  Luis A Ortiz-Rodríguez; Sean J Hoehn; Axel Loredo; Lushun Wang; Han Xiao; Carlos E Crespo-Hernández
Journal:  J Am Chem Soc       Date:  2021-02-15       Impact factor: 15.419

4.  Photodissociation of a ruthenium(II) arene complex and its subsequent interactions with biomolecules: a density functional theory study.

Authors:  Hanlu Wang; Nathan J DeYonker; Xiting Zhang; Cunyuan Zhao; Liangnian Ji; Zong-Wan Mao
Journal:  J Mol Model       Date:  2012-06-01       Impact factor: 1.810

5.  Rhodium(III) and iridium(III) complexes with 1,2-naphthoquinone-1-oximate as a bidentate ligand: synthesis, structure, and biological activity.

Authors:  Stefan Wirth; Christoph J Rohbogner; Marcin Cieslak; Julia Kazmierczak-Baranska; Stefan Donevski; Barbara Nawrot; Ingo-Peter Lorenz
Journal:  J Biol Inorg Chem       Date:  2009-12-19       Impact factor: 3.358

6.  Asymmetric transfer hydrogenation by synthetic catalysts in cancer cells.

Authors:  James P C Coverdale; Isolda Romero-Canelón; Carlos Sanchez-Cano; Guy J Clarkson; Abraha Habtemariam; Martin Wills; Peter J Sadler
Journal:  Nat Chem       Date:  2018-01-08       Impact factor: 24.427

7.  Organometallic 3-(1H-benzimidazol-2-yl)-1H-pyrazolo[3,4-b]pyridines as potential anticancer agents.

Authors:  Iryna N Stepanenko; Maria S Novak; Gerhard Mühlgassner; Alexander Roller; Michaela Hejl; Vladimir B Arion; Michael A Jakupec; Bernhard K Keppler
Journal:  Inorg Chem       Date:  2011-10-27       Impact factor: 5.165

Review 8.  Thionated organic compounds as emerging heavy-atom-free photodynamic therapy agents.

Authors:  Luis A Ortiz-Rodríguez; Carlos E Crespo-Hernández
Journal:  Chem Sci       Date:  2020-09-22       Impact factor: 9.825

9.  Pt(II)-Thiocarbohydrazone Complex as Cytotoxic Agent and Apoptosis Inducer in Caov-3 and HT-29 Cells through the P53 and Caspase-8 Pathways.

Authors:  Abeer A Ibrahim; Mohanad M Kareem; Taghreed H Al-Noor; Tahani Al-Muhimeed; Abeer A AlObaid; Salim Albukhaty; Ghassan M Sulaiman; Majid Jabir; Zainab J Taqi; Usama I Sahib
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-26

10.  Antinociceptive and antitumor activity of novel synthetic mononuclear Ruthenium (II) compounds.

Authors:  Shyam Sunder A; Satyavati Dhulipala; Sreekanth Thota; Rajeshwar Yerra; Jan Balzarini; Erik De Clercq
Journal:  J Res Med Sci       Date:  2013-03       Impact factor: 1.852
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.